Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma
Novartis
Novartis
Xencor, Inc.
M.D. Anderson Cancer Center
Vanderbilt-Ingram Cancer Center
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
University of Bologna
City of Hope Medical Center
Celgene